Autopsy report · NCT00985946

Study of Panobinostat in Patients With Neuroendocrine Tumors

“Study did not meet statistical requirements to continue.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 8 months before it started.
• Ran for about 4 years 11 months before it stopped.
• 15 participants enrolled.
• Results were posted on the registry 2 years 3 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

University of Wisconsin, Madison

Sponsor type

University, hospital or other

Conditions

Neuroendocrine Tumors

Interventions

panobinostat (LBH589)

Participants

15

Sites

1

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.